Scientific project design in translational oncology
BIO-488
- News forum (Forum)
- Review on TME 2012 (File)
- Lecture (File)
- Using PubMed (File)
- Review on transgenic mice (File)
- Review on mouse cancer models (File)
- Presentation on transgenic mice / cancer models (2021) (File)
- First assignment (group A) for Sept 18 (File)
- Review on angiogenesis 2017 (check section on macrophages and angiogenesis) (File)
- Review of angiogenesis 2024 (check "milestone 4") (File)
- Macrophages & angiogenesis_Pollard Cancer Res 2006 (for Sept 18) (File)
ALL PRESENTATIONS START AT 9:00 SHARP.
- Second assignment (group B) for Sept 25 (File)
- Review on TAMs and invasion and metastasis (File)
- Review on TAMs (more general) (File)
- Paper group B (File)
- Third assignment (for Oct 2) (File)
- Myeloid cells and metastasis (File)
- Neutrophils and cancer (File)
- Paper group C (File)
30 September - 06 October
07 October - 13 October
14 October - 20 October
28 October - 03 November
4 November - 10 November
- 8th assignment (group D, second round) for Nov 13 (File)
- Review (T cell therapies) (File)
- Review (DC therapies) (File)
- Paper group D (for Nov 13) (File)
11 November - 17 November
Last presentation
18 November - 24 November
The four groups will present their first ideas about the project (group A --> D order).
Group A will start at 8:40 sharp. Please verify before the start that your laptop projects well.
Each group will present 1-3 slides. If not interrupted, each group should speak for about 5 minutes. With our suggestions and discussion, each group will take a maximum of 15-20 minutes.
- Medical need and disease focus (type of cancer or disease stage)
- Target molecule or cell type, if any is pre-selected (e.g., oncogenic protein, tumor-promoting neutrophils, etc.). In some projects, there is no such target available to begin with, as the project may involve screening for new targets.
- The strategy at a glance (a new approach for, e.g., diagnostics, monitoring, or treatment of cancer)
- The key steps of the project (e.g., from screening/validation, to mouse or ex vivo experiments, to the design of a first clinical trial)
We look for new ideas, but you can use available approaches to be fine tuned/modified. The project should be feasible, so you will have to document the steps that you will make to experimentally test your approach.
25 November - 1 December
We start at 9 am with group A.
2 December - 9 December
FINAL PRESENTATIONS IN PERSON:
Dec 20 from 9 am until 12 am. Room SV 3615.
Each presentation should not exceed 20-25 min without interruptions. There may be some questions, during but especially after the presentation, but each presentation slot will not exceed 40 mins with questions.
Everybody should be present and there can be questions from other students, time permitting.
Please add a picture of you with your name on the first (or second) slide.